4-year mortality in patients with non-small-cell lung cancer: development and validation of a prognostic index
The Lancet OncologyPublished 9 September 2006
F Blanchon, M Grivaux, Bernard Asselain, F.-X. Lebas, J.-P. Orlando, J. Piquet
Citations125
SJR quartileQ1
SJR score11.32
SNIP10.23
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
This prognostic index, incorporating personal, tumour, and functional information would be helpful in guiding patient management, resource use, and the design of clinical trials.
Abstract
This prognostic index, incorporating personal, tumour, and functional information would be helpful in guiding patient management, resource use, and the design of clinical trials.
Keywords
Medicine
CA A Cancer Journal for CliniciansGlobal cancer statistics
54,961 Citations2011Ahmedin Jemal, Freddie Bray +3 more
A substantial proportion of the worldwide burden of cancer could be prevented through the application of existing cancer control knowledge and by implementing programs for tobacco control, vaccination, and early detection and treatment, as well as public health campaigns promoting physical activity and a healthier dietary intake.
CA A Cancer Journal for CliniciansGlobal Cancer Statistics, 2002
18,390 Citations2005Donald Maxwell Parkin, Freddie Bray +2 more
There are striking variations in the risk of different cancers by geographic area, most of the international variation is due to exposure to known or suspected risk factors related to lifestyle or environment, and provides a clear challenge to prevention.
American Journal of Clinical OncologyToxicity and response criteria of the Eastern Cooperative Oncology Group
11,623 Citations1982Martin M. Oken, Richard H. Creech +5 more
The Eastern Cooperative Oncology Group criteria for toxicity and response are presented to facilitate future reference and to encourage further standardization among those conducting clinical trials.
BiometrikaProportional hazards tests and diagnostics based on weighted residuals
5,601 Citations1994Patricia M. Grambsch, Terry M. Therneau
CHEST JournalRevisions in the International System for Staging Lung Cancer
4,598 Citations1997Clifton F. Mountain
Analysis of a collected database representing all clinical, surgical-pathologic, and follow-up information for 5,319 patients treated for primary lung cancer confirmed the validity of the TNM and stage grouping classification schema.
JNCI Journal of the National Cancer InstituteAnnual Report to the Nation on the Status of Cancer, 1975–2002, Featuring Population-Based Trends in Cancer Treatment
951 Citations2005Brenda K. Edwards, Martin L. Brown +13 more
Cancer death rates for all cancer sites combined and for many common cancers have declined at the same time as the dissemination of guideline-based treatment into the community has increased, although this progress is not shared equally across all racial and ethnic populations.
Journal of Clinical OncologyEpidermal Growth Factor Receptor Gene Mutations and Increased Copy Numbers Predict Gefitinib Sensitivity in Patients With Recurrent Non–Small-Cell Lung Cancer
708 Citations2005Toshimi Takano, Yuichiro Ohe +13 more
EGFR mutations and increased copy numbers were significantly associated with better clinical outcome in gefitinib-treated NSCLC patients.
CHEST JournalPrognostic Factors in Non-small Cell Lung Cancer
571 Citations2002Michael Brundage, Diane Davies +1 more
While the breadth of prognostic factors studied in the literature is extensive, the scope of factors evaluated in individual studies is inappropriately narrow and individual studies are typically statistically underpowered and remarkably heterogeneous with regard to their conclusions.
American Journal of Respiratory and Critical Care MedicineOne Hundred Years of Lung Cancer
384 Citations2005Stephen Spiro, Gerard A. Silvestri
The management of small cell lung cancer, which appeared so promising at the beginning of the 1970s, has hit a plateau with very little advance in outcome over the last 15 years.
Lung CancerThe changing epidemiology of lung cancer in Europe
299 Citations2003M.L.G. Janssen‐Heijnen
The epidemic of lung cancer is not over yet, especially in southern and eastern Europe, and prevention remains the best policy, but improvement in the management of Lung cancer also remains very important.
CHEST JournalLung Cancer in Women
286 Citations2005Jennifer B. Fu, T. Kau +2 more
The incidence rate of lung cancer in women in the United States has reached a plateau, however, women are relatively overrepresented among younger patients, raising the question of gender-specific differences in the susceptibility to lung carcinogens.
The Annals of Thoracic SurgeryGender differences in non–small-cell lung cancer survival: an analysis of 4,618 patients diagnosed between 1997 and 2002
279 Citations2004A. Visbal, Brent A. Williams +8 more
Male gender is confirmed to be an independent unfavorable prognostic indicator for NSCLC survival as well as stage III/IV disease or adenocarcinoma.
Journal of Clinical OncologyFrequency and prognostic importance of pretreatment clinical characteristics in patients with advanced non-small-cell lung cancer treated with combination chemotherapy.
241 Citations1986Joseph O’Connell, Mark G. Kris +7 more
Information from this analysis may be useful when comparing the response data of completed studies in similar patients, in designing future trials, and in the selection of cisplatin plus vinca alkaloid therapy for individual patients with advanced NSCLC.
Supportive Care in CancerObserver error in grading performance status in cancer patients
141 Citations1999Anita Taylor, Ian Olver +3 more
It is concluded that either scale could be used with good interobserver reliability and the ECOG scale minimises differences between observers.
European Respiratory JournalPrognostic factors in lung cancer: tables and comments
126 Citations1994G Buccheri, Domenico Ferrigno
This paper attempts to provide a comprehensive listing of PFs and other variables potentially associated with outcome of lung cancer using tables, where studies relevant to each PF are referenced in relationship to their results, statistical power, type of analysis, number of variables incorporated in multivariate tests, and cell type.
Journal of Clinical OncologySmoking Before Surgery Predicts Poor Long-Term Survival in Patients With Stage I Non–Small-Cell Lung Carcinomas
125 Citations1999Takehiko Fujisawa, Toshihiko Iizasa +7 more
Smoking pack-years is an important clinical prognostic factor in evaluating overall long-term survival in patients with stage I primary, resected NSCLC and demonstrated significant correlations between overall survival and age and pack- years.
Cancer Epidemiology Biomarkers & PreventionUnlimited Access to Care: Effect on Racial Disparity and Prognostic Factors in Lung Cancer
110 Citations2006Charles R. Mulligan, Amir D. Meram +4 more
No racial disparities in survival when access to medical care is universal is observed, and male gender, incomplete resection, and advanced stage are significant predictors of poor outcome in lung cancer.
Journal of Clinical OncologyUnraveling the Mystery of Prognostic and Predictive Factors in Epidermal Growth Factor Receptor Therapy
106 Citations2006Frances A. Shepherd, Ming‐Sound Tsao
The presence of classical EGFR mutations confer a favorable prognosis and that the superior survival reported for mutation-positive patients from single-arm studies may not have been a result of a greater benefit from the EGFR inhibitor in these patients.
PubMed[Epidemiologic of primary bronchial carcinoma management in the general French hospital centers].
87 Citations2002F Blanchon, M Grivaux +9 more
Respiratory physicians in general hospitals manage more than a quarter of the cases of bronchial carcinoma seen annually in France, with a significant percentage of non-smokers and adenocarcinomas.
Lung CancerDuration of smoking abstinence as a predictor for non-small-cell lung cancer survival in women
65 Citations2004Jon O. Ebbert, Brent A. Williams +6 more
The identification of smoking history as a prognostic factor in lung cancer survival supports previous research suggesting a direct biologic effect of smoking on survival, however, this effect may vary by sex and type of lung cancer.
The Annals of Thoracic SurgeryPreoperative pulmonary function as a prognostic factor for stage I non–small cell lung carcinoma
43 Citations2004Toshihiko Iizasa, Makoto Suzuki +9 more
Lobectomy may not be preferred as an appropriate surgical modality for patients with stage I non-small cell lung carcinoma with small peripheral nodules who exhibit poor pulmonary function, especially lowered FEV(1)%.
British Journal of CancerNon-small-cell lung cancer in a French department, (1982–1997): management and outcome
39 Citations2005J. Foeglé, Guy Hédelin +4 more
Overall survival did not improve over time despite changes in treatment in accordance with the state-of-the-art, and it is not unlikely that more patients with bad PS were diagnosed during the latter end of the study period.
Lung CancerPrognosis of Stage II non-small cell lung cancer according to tumor and nodal status at diagnosis
36 Citations2005Juan P. Wisnivesky, Claudia I. Henschke +2 more
Among Stage II cancers, T3N0 cases have the highest cure rate and an overall survival pattern that more closely resembles T1N1 tumors, suggesting that T3n0 cases may be better classified as Stage IIA disease.
PubMed[Frequency of cancer in France: 2004 update].
29 Citations2004Catherine Hill, F Doyon
The tobacco-related lung cancer epidemic is accelerating markedly in the female population and is beginning to decrease in the male population.
Lung CancerLung cancer among women in France.
23 Citations2004M Grivaux, Jean Luc Breton +10 more
According to multivariate analysis, adenocarcinoma is related to less smoking and younger age, and appears to be the most frequent form and more often at a metastatic stage.
Revue des Maladies RespiratoiresCohorteKbp-2000-Cphg : évaluation des facteurs pronostiques de la survie du cancer bronchique primitif à 2 et 5 ans
22 Citations2006F Blanchon, M Grivaux +12 more
Materiel et methodes KBP-2000-CPHG est un travail epidemiologique mene durant toute l’annee 2000 sur les cancers bronchiques primitifs histologiquement prouves et pris en charge dans les hopitaux generaux.
Journal of Clinical OncologyAccuracy of Recorded Tumor, Node, and Metastasis Stage in a Comprehensive Cancer Center
16 Citations2002James D. Brierley
This audit demonstrates the importance of staging and provides impetus to develop staging guidelines and education programs.
CHEST JournalSurvival of 2,991 Patients With Surgical Lung Cancer
16 Citations2005Á. López Encuentra
This study detected that there are no prognostic differences between pIB and pIIA, and between pIIIA and pIIIB, in the current staging system of lung cancer.
Lung CancerSurgical lung cancer
15 Citations2004Á. López Encuentra, Francisco Pozo-Rodrı́guez +5 more
The numerous variables under analysis are poorly associated with morbidity or mortality after thoracotomy in lung cancer.
PubMed[Frequency of cancer in France].
11 Citations2003Catherine Hill, F Doyon
The most recent cancer mortality and morbidity data available for France are presented and tumours are the first cause of death among men and the second most common among women after cardiovascular diseases.